Epilepsy

Future studies may validate the use of routine electroencephalogram as an alternative to continuous electroencephalogram in centers with limited resources, as despite better seizure detection with continuous monitoring, outcomes were similar between the methods.

Neurology News Network for the week ending August 8, 2020.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending August 7, 2020.

Marinus Pharmaceuticals, the agent’s manufacturer, plans to announce topline data from the phase 3 Marigold study in the third quarter of this year.

An overview of the tweet chat on mental health in neurological disorders, featuring highlighted contributions from the medical community.

The approval also expands the age range of all Epidiolex indications to include patients age 1 and older.

NeuroPace’s FDA-approved neurostimulation device helped 35% of patients with epilepsy achieve ≥90% reduction in seizure frequency, with 18% of patients reporting seizure freedom at last follow-up.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending July 31, 2020.

Join NeurologyLive and the Women Neurologist Group on Twitter to discuss the importance of mental health and wellness in neurologic disorders.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending July 24, 2020.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending July 17, 2020.

A retrospective analysis suggests that normalizing the spatial proximity between nearby electrodes and more extensive electrode coverage improved the accuracy of post-surgery seizure outcomes.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending July 10, 2020.

Despite the ongoing public health emergency, many of the telehealth policies established by the CARES Act waiver are expiring.

The lack of effect on cognitive function provides reassurance to clinicians and parents for the developmental outcomes of a well-recognized, albeit relatively uncommon, adverse event after immunization.

A look at the questions you should be asking during the decision-making process of picking a telehealth vendor.

Neurology News Network for the week ending July 4, 2020.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending July 3, 2020.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending June 26, 2020.

Fintepla, marketed by Zogenix, will be available for prescription for the rare pediatric epilepsy syndrome beginning in July 2020 through a REMS program.

The Medtronic device is the only DBS system that is eligible to be used for both 3T and 1.5T full-body MRI scans, with the first implant procedure scheduled at Mayo Clinic.

Preliminary findings from a retrospective sample series in the Bronx, New York.

The partnership will combine 2 databases with robust historical data in hopes of empowering both research and physician communities and ultimately improving clinical care for patients with tuberous sclerosis complex.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending June 19, 2020.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending June 12, 2020.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending June 5, 2020.

The chief of pediatric neurology at the University of Tennessee Health Science Center, and director of the Comprehensive Epilepsy Program at Le Bonheur Children's Hospital spoke to the difficulty in connecting with colleagues with virtual meetings.

Cenobamate may offer a potential treatment option for patients who continue to have seizures despite the use of available treatments.

The chief of pediatric neurology at the University of Tennessee Health Science Center, and director of the Comprehensive Epilepsy Program at Le Bonheur Children's Hospital discussed the current state of research in epilepsy care.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending May 29, 2020.